Search hospitals > Rhode Island > Providence
Rhode Island Hospital
Claim this profileProvidence, Rhode Island 02903
Global Leader in Leukemia
Global Leader in Cancer
Conducts research for Tumors
Conducts research for Lymphoma
Conducts research for Breast Cancer
856 reported clinical trials
62 medical researchers
Summary
Rhode Island Hospital is a medical facility located in Providence, Rhode Island. This center is recognized for care of Leukemia, Cancer, Tumors, Lymphoma, Breast Cancer and other specialties. Rhode Island Hospital is involved with conducting 856 clinical trials across 969 conditions. There are 62 research doctors associated with this hospital, such as Jennifer J. Welch, Benedito Carneiro, Adam J. Olszewski, and Eric Wong, MD.Area of expertise
1Leukemia
Global LeaderPhiladelphia chromosome positive
NTRK1 positive
NTRK positive
2Cancer
Global LeaderStage IV
Stage I
Stage II
Top PIs
Jennifer J. WelchRhode Island Hospital7 years of reported clinical research
Expert in Tumors
Expert in Brain Tumor
45 reported clinical trials
107 drugs studied
Benedito CarneiroLifespan Cancer Institute2 years of reported clinical research
Studies Solid Tumors
Studies Tumors
11 reported clinical trials
21 drugs studied
Adam J. OlszewskiRhode Island Hospital3 years of reported clinical research
Studies Lymphoma
Studies Mantle Cell Lymphoma
10 reported clinical trials
25 drugs studied
Eric Wong, MDBeth Israel Deaconess Medical Center1 year of reported clinical research
Studies Cancer
Studies Brain Tumor
8 reported clinical trials
15 drugs studied
Clinical Trials running at Rhode Island Hospital
Breast Cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Tumors
Lung Cancer
Cancer
Lymphoma
Prostate Cancer
Solid Tumors
Ovarian Tumors
Sacituzumab Govitecan + Pembrolizumab
for Triple-Negative Breast Cancer
This trial compares the effectiveness of a combination of two drugs, SG and pembrolizumab, in patients with advanced triple-negative breast cancer. SG targets and kills cancer cells with chemotherapy, while pembrolizumab helps the immune system attack the cancer. Pembrolizumab has been shown to improve survival in various cancers, including triple-negative breast cancer, when used alone or in combination with other treatments.
Recruiting4 awards Phase 3
Imlunestrant
for Early Breast Cancer
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Recruiting2 awards Phase 36 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Rhode Island Hospital?
Rhode Island Hospital is a medical facility located in Providence, Rhode Island. This center is recognized for care of Leukemia, Cancer, Tumors, Lymphoma, Breast Cancer and other specialties. Rhode Island Hospital is involved with conducting 856 clinical trials across 969 conditions. There are 62 research doctors associated with this hospital, such as Jennifer J. Welch, Benedito Carneiro, Adam J. Olszewski, and Eric Wong, MD.
Where is Rhode Island Hospital located?
To reach Rhode Island Hospital in Providence, RI, take exit 20 from I-95 North and follow signs for Point Street. Turn left onto Friendship Street at the end of the ramp, then continue straight to 593 Eddy Street. Alternatively, GPS navigation services like MapQuest or Waze can provide real-time driving directions.
Who should I call to ask about financial aid or insurance network?
**Rhode Island Hospital Financial Assistance:**
- For financial assistance, contact the Patient Financial Advocacy Program at (401) 788-1383. Assistance is available for uninsured Rhode Island residents meeting income criteria.
- The Charity Care program aids uninsured, low-income residents who cannot access state, federal, or employer-sponsored health insurance.
**Insurance Inquiries:**
- For insurance questions or help understanding hospital bills, call customer service at 1-800-884-6966.
What insurance does Rhode Island Hospital accept?
Rhode Island Hospital accepts a wide range of insurance plans, including but not limited to Aetna, Blue Cross Blue Shield of Rhode Island, Harvard Pilgrim Health Care, and United HealthCare. Note that fees for personal physicians, specialists, and private duty nurses might not be included in the hospital's billing. Island Health also accepts various insurances, such as Aetna, Cigna, Kaiser Permanente, Medicare, and United Healthcare.
What awards or recognition has Rhode Island Hospital received?
Rhode Island Hospital, located in Providence, Rhode Island, is a distinguished facility recognized for its excellence in research and care. It has been named a Blue Distinction Center for both Cancer Care and Cardiac Care by the Blue Cross Blue Shield Association. The hospital is also notable for ranking 13th among independent hospitals in National Institutes of Health funding, receiving over $27 million annually, and has earned the Get With The Guidelines-Stroke Gold Plus award from the American Heart Association/American Stroke Association, including honors in Stroke Elite Plus, Stroke Advanced Therapy, and Type 2 Diabetes.